secwatch.observer — SEC 8-K summary
======================================

Issuer:     PDS Biotechnology Corp (PDSB)
CIK:        0001472091
Form:       8-K
Filed at:   2026-04-24T23:59:59+00:00
Accession:  0001140361-26-016684
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PDS Biotechnology updates corporate presentation deck; no material operational or financial changes disclosed
--------------------------------------------------------------------------------

- Filing indicates only an updated investor presentation (Exhibit 99.1) was published.
- No new clinical data, partnership, or financial metrics provided in the filing.
- Slide deck cover: 'Precision Designed Science for Cancer Patients' with April 2026 date.
- Investors should rely on prior disclosures for current business outlook.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472091/000114036126016684/0001140361-26-016684-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472091/000114036126016684/ef20071434_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-016684

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer